Beta Bionics BBNX
NASDAQ BBNX
$18.65 -0.22 (-1.17%)
As of: Oct 2, 2026 · 2:11 PM EDT

Beta Bionics (BBNX) Return on Assets [ROA] (2025 - 2026)

Updated

Beta Bionics (BBNX) posted Return on Assets [ROA] of -24.45% for Q2 2026, down 7.89 percentage points from -16.56% a year earlier and down 3.47 percentage points from the prior quarter.

Analysis

Beta Bionics (BBNX) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Beta Bionics' Return on Assets [ROA] came in at -25.40%, up 6.44 percentage points from FY2024.

  • In prior years, Beta Bionics' Return on Assets [ROA] was -31.84% in FY2024.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -20.99% (Q1 2026), -18.44% (Q4 2025) and -17.99% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 6.17%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 4.94%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 4.54%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 15.41%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 5.66%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -1.94%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 8.19%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 7.38%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 1.85%
10 Beta Bionics 853.75 Mn 25.93 Mn 18.90 Mn -24.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.45%
Mar 31, 2026 -20.99%
Dec 31, 2025 -18.44%
Sep 30, 2025 -17.99%
Jun 30, 2025 -16.56%
Mar 31, 2025 -20.19%
API Access

Beta Bionics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BBNX&period=max&api_key=YOUR_API_KEY